216.98
前日終値:
$215.13
開ける:
$214.74
24時間の取引高:
295.52K
Relative Volume:
0.17
時価総額:
$51.05B
収益:
$244.67B
当期純損益:
$1.68B
株価収益率:
31.23
EPS:
6.9487
ネットキャッシュフロー:
$5.51B
1週間 パフォーマンス:
+1.36%
1か月 パフォーマンス:
-2.40%
6か月 パフォーマンス:
+38.00%
1年 パフォーマンス:
+66.31%
Cardinal Health Inc Stock (CAH) Company Profile
Compare CAH vs MCK, COR, HSIC, AHG
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
CAH
Cardinal Health Inc
|
216.96 | 50.62B | 244.67B | 1.68B | 5.51B | 6.9487 |
|
MCK
Mckesson Corporation
|
875.02 | 106.71B | 397.96B | 4.55B | 9.64B | 34.77 |
|
COR
Cencora Inc
|
322.80 | 63.21B | 325.78B | 1.64B | 3.61B | 8.3139 |
|
HSIC
Henry Schein Inc
|
75.90 | 8.67B | 13.18B | 419.00M | 521.00M | 3.2704 |
|
AHG
Akso Health Group Adr
|
2.23 | 1.96B | 14.85M | -136.07M | 7.23M | -0.4726 |
Cardinal Health Inc Stock (CAH) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-09 | アップグレード | Citigroup | Neutral → Buy |
| 2025-12-09 | 開始されました | Barclays | Overweight |
| 2025-06-03 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2025-02-05 | アップグレード | Jefferies | Hold → Buy |
| 2025-01-08 | アップグレード | TD Cowen | Hold → Buy |
| 2025-01-07 | アップグレード | Evercore ISI | In-line → Outperform |
| 2025-01-06 | アップグレード | BofA Securities | Neutral → Buy |
| 2024-12-13 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2024-12-04 | 再開されました | Mizuho | Outperform |
| 2024-02-26 | 開始されました | Leerink Partners | Outperform |
| 2024-02-09 | アップグレード | Argus | Hold → Buy |
| 2024-01-03 | 開始されました | Barclays | Overweight |
| 2023-12-14 | 開始されました | Wells Fargo | Underweight |
| 2023-07-10 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2023-03-31 | 開始されました | Citigroup | Neutral |
| 2023-02-03 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2022-11-04 | アップグレード | BofA Securities | Underperform → Neutral |
| 2022-08-22 | 再開されました | Morgan Stanley | Overweight |
| 2022-05-26 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2022-05-18 | アップグレード | Evercore ISI | In-line → Outperform |
| 2022-04-12 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2022-04-01 | 再開されました | Credit Suisse | Neutral |
| 2021-08-06 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2021-08-05 | ダウングレード | BofA Securities | Buy → Underperform |
| 2021-05-10 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2021-01-08 | アップグレード | Wolfe Research | Underperform → Peer Perform |
| 2020-11-02 | アップグレード | Barclays | Equal Weight → Overweight |
| 2020-09-25 | アップグレード | Deutsche Bank | Hold → Buy |
| 2020-07-20 | アップグレード | Guggenheim | Neutral → Buy |
| 2020-05-15 | アップグレード | UBS | Neutral → Buy |
| 2020-04-23 | 再開されました | Credit Suisse | Neutral |
| 2020-03-20 | アップグレード | BofA/Merrill | Underperform → Buy |
| 2020-02-12 | アップグレード | Morgan Stanley | Underweight → Equal-Weight |
| 2020-02-07 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2019-12-16 | ダウングレード | Guggenheim | Buy → Neutral |
| 2019-09-12 | 開始されました | Deutsche Bank | Hold |
| 2019-08-27 | ダウングレード | Argus | Buy → Hold |
| 2019-08-20 | アップグレード | Guggenheim | Neutral → Buy |
| 2019-04-18 | 開始されました | Guggenheim | Neutral |
| 2019-01-17 | 開始されました | UBS | Neutral |
| 2018-11-16 | ダウングレード | Leerink Partners | Outperform → Mkt Perform |
| 2018-04-24 | アップグレード | Leerink Partners | Mkt Perform → Outperform |
| 2018-04-02 | アップグレード | Argus | Hold → Buy |
| 2018-03-08 | 開始されました | Barclays | Equal Weight |
| 2018-02-27 | 再開されました | BofA/Merrill | Underperform |
| 2018-01-05 | 開始されました | Evercore ISI | In-line |
すべてを表示
Cardinal Health Inc (CAH) 最新ニュース
Robotic Pharmacy Prescription Market Research and Global Forecast Report 2025-2032 - GlobeNewswire Inc.
Here’s Why Investing in Cardinal Health Shares Could Benefit Your Portfolio Right Now - Bitget
Cardinal Health (CAH) Gains But Lags Market: What You Should Know - Yahoo Finance Singapore
Cardinal Health Inc. stock rises Wednesday, still underperforms market - MarketWatch
Here's Why You Should Add Cardinal Health Stock to Your Portfolio Now - TradingView
Is Cardinal Health (CAH) Stock Undervalued Right Now? - Yahoo Finance
A Look At Cardinal Health (CAH) Valuation After Expanded Actinium-225 Cancer Therapy Production - Sahm
Cardinal Health, Inc. (CAH) stock price, news, quote and history - Yahoo Finance UK
Longtime supervisor sues Cardinal Health over age and gender bias - hcamag.com
Cardinal Health, Inc. (CAH) Stock Price, News, Quote & History - Yahoo! Finance Canada
Cardinal Health ER Laceration Tray ACS-SLAC1 | Health Supply 770 INC - primetimes.id
Cardinal Health (NYSE:CAH) Upgraded at Wall Street Zen - MarketBeat
Global Clinical Drainage Supplies Market Dominated by North America as Cardinal Health and Medline Expand Products - WFMZ.com
Wells Fargo raises outlook on Cardinal Health (CAH), cites broad business strength - MSN
Tema Etfs LLC Trims Cardinal Health Stock Position - National Today
Tema Etfs LLC Decreases Stock Position in Cardinal Health, Inc. $CAH - MarketBeat
9 Best-Performing Health Care Stocks for April 2026 - NerdWallet
Cardinal Health Inc (CLH.SG) stock price, news, quote and history - Yahoo Finance UK
Cardinal Health Increases Ac-225 Production to Enhance Cancer Treatment Options - Bitget
Cardinal Health Expands Ac-225 Capacity to Boost Cancer Therapies - Yahoo Finance
HF Advisory Group LLC Buys 5,049 Shares of Cardinal Health, Inc. $CAH - MarketBeat
Kwmg LLC Has $16.51 Million Position in Cardinal Health, Inc. $CAH - MarketBeat
Cardinal Health Deepens Actinium-225 Role As Board Leadership Shifts - Yahoo Finance
Cardinal Health, Shine Technologies amp up domestic production of radiopharmaceuticals - Healthcare Brew
Cardinal Health (CAH) Boosts Actinium-225 Production for Future Therapies - GuruFocus
Can CAH's Specialty Flywheel Strategy Unlock Long-Term Growth? - The Globe and Mail
Cardinal Health (CAH) Boosts Actinium-225 Production Capacity - GuruFocus
Insiders At Cardinal Health Sold US$53m In Stock, Alluding To Potential Weakness - Yahoo Finance
Nisa Investment Advisors LLC Trims Stock Position in Cardinal Health, Inc. $CAH - MarketBeat
Cancer drug developers get more Actinium-225 as Cardinal Health expands - Stock Titan
List of 30 Acquisitions by Cardinal Health (Apr 2026) - Tracxn
Can CAH’s Unique Specialty Flywheel Approach Drive Sustainable Growth Over Time? - Bitget
Cardinal Health, Inc. (NYSE:CAH) Short Interest Up 21.1% in March - MarketBeat
Did Cardinal Health's (CAH) New Chair and Urology Deal Just Reframe Its Healthcare Partnership Strategy? - Sahm
Cardinal Health (CAH) Increases Yet Falls Behind Market: What Investors Need to Know - Yahoo Finance Singapore
Cardinal Health Inc. stock rises Tuesday, still underperforms market - MarketWatch
Here's why you should add Cardinal Health stock to your portfolio now - MSN
Cardinal Health, Inc.: - marketscreener.com
Cardinal Health, Inc. $CAH Shares Sold by Wedge Capital Management L L P NC - MarketBeat
-0.54% for Cardinal Health stock as price stays below key moving averages - Traders Union
Jim Cramer on Cardinal Health: "I want you to buy it and buy it, get this, aggressively" - MSN
Jim Cramer on Cardinal Health: “I Want You to Buy It and Buy It, Get This, Aggressively” - Insider Monkey
UBS reiterates Buy on Cardinal Health stock, $260 price target - Investing.com
Global X Japan Co. Ltd. Increases Position in Cardinal Health, Inc. $CAH - MarketBeat
Bethlehem - dailyvoice.com
Cardinal Health (CAH) Stock Moves -1.71%: What You Should Know - Yahoo Finance
Why The Narrative Around Cardinal Health (CAH) Is Shifting With New Targets And Guidance - Yahoo Finance
Cardinal Health Inc. stock outperforms competitors despite losses on the day - MarketWatch
Vanguard (CAH) parent reports zero CAH holdings after realignment - Stock Titan
Cardinal Health (CAH) Appoints New Chair as Gregory Kenny Steps Down - insidermonkey.com
Alcohol Prep Pads Recalled Over Bacteria Risk, Cardinal Health Says - Infectious Disease Advisor
Cardinal Health Inc (CAH) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):